Population-specific design of de-immunized protein biotherapeutics

Benjamin Schubert, Charlotta Schärfe, Pierre Dönnes +3

Immunogenicity is a major problem during the development of biotherapeutics since it can lead to rapid clearance of the drug and adverse reactions. The challenge for biotherapeutic…